Medibank Private Beheer

Beheer criteriumcontroles 4/4

De CEO Medibank Private is David Koczkar, benoemd in May2021, heeft een ambtstermijn van 3.5 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 80.11K, bestaande uit 34.8% salaris en 65.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.068% van de aandelen van het bedrijf, ter waarde € 4.21M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.5 jaar en 3.5 jaar.

Belangrijke informatie

David Koczkar

Algemeen directeur

AU$80.1k

Totale compensatie

Percentage CEO-salaris	34.8%
Dienstverband CEO	3.5yrs
Eigendom CEO	0.07%
Management gemiddelde ambtstermijn	3.5yrs
Gemiddelde ambtstermijn bestuur	3.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is David Koczkar's beloning veranderd ten opzichte van Medibank Private's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$80k	AU$28k	AU$4m
Mar 31 2024	n/a	n/a	AU$89m
Dec 31 2023	n/a	n/a	AU$685m
Sep 30 2023	n/a	n/a	AU$598m
Jun 30 2023	AU$3m	AU$2m	AU$0
Mar 31 2023	n/a	n/a	AU$171m
Dec 31 2022	n/a	n/a	AU$343m
Sep 30 2022	n/a	n/a	AU$368m
Jun 30 2022	AU$4m	AU$2m	AU$394m
Mar 31 2022	n/a	n/a	AU$414m
Dec 31 2021	n/a	n/a	AU$435m
Sep 30 2021	n/a	n/a	AU$438m
Jun 30 2021	AU$2m	AU$1m	AU$441m
Mar 31 2021	n/a	n/a	AU$402m
Dec 31 2020	n/a	n/a	AU$363m
Sep 30 2020	n/a	n/a	AU$340m
Jun 30 2020	AU$1m	AU$919k	AU$316m
Mar 31 2020	n/a	n/a	AU$368m
Dec 31 2019	n/a	n/a	AU$420m
Sep 30 2019	n/a	n/a	AU$429m
Jun 30 2019	AU$2m	AU$866k	AU$438m
Dec 31 2018	n/a	n/a	AU$375m
Sep 30 2018	n/a	n/a	AU$400m
Jun 30 2018	AU$2m	AU$802k	AU$424m

Compensatie versus markt: De totale vergoeding ($USD 52.65K ) David } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 3.43M ).

Compensatie versus inkomsten: De vergoeding van David is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

David Koczkar (51 yo)

3.5yrs

Tenure

AU$80,106

Compensatie

Mr. David Koczkar, BCom, PG Dip Finance, MAICD, serves as Managing Director, Director and Chief Executive Officer at Medibank Private Limited since May 17, 2021 and served as Group Executive and Chief Cust...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
David Koczkar	CEO, MD & Director	3.5yrs	AU$80.11k	0.068% € 4.2m
Mark Rogers	Group Lead - Chief Financial Officer & Group Strategy	7.8yrs	AU$39.24k	0.029% € 1.8m
Andrew Wilson	Group Chief Medical Officer	14.3yrs	AU$25.02k	0% € 0
Milosh Milisavljevic	Group Lead - Chief Customer Officer	3.4yrs	AU$34.73k	0.0057% € 348.3k
Robert Read	Group Lead – Amplar Health	less than a year	AU$19.03k	geen gegevens
Felicia Trewin	Group Lead – Data & Technology	less than a year	geen gegevens	geen gegevens
Colette Campbell	Senior Executive of Investor Relations	no data	geen gegevens	geen gegevens
Mei Ramsay	Group Lead – Trust	10.1yrs	AU$1.03m	geen gegevens
Tom Exton	Group Lead - Chief Risk & Compliance Officer	less than a year	geen gegevens	geen gegevens
Emily Ritchie	Senior Executive of External Affairs	no data	geen gegevens	geen gegevens
Kylie Bishop	Group Lead – People	11.3yrs	AU$1.10m	geen gegevens
Meaghan Telford	Group Lead of Policy	no data	geen gegevens	geen gegevens

3.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van MPV wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
David Koczkar	CEO, MD & Director	3.5yrs	AU$80.11k	0.068% € 4.2m
Linda Nicholls	Independent Non-Executive Director	10.7yrs	AU$4.23k	0.0018% € 112.6k
Kathryn Fagg	Independent Non-Executive Director	2.7yrs	AU$3.80k	0.0024% € 146.5k
Michael Wilkins	Independent Non-Executive Chairman	7.5yrs	AU$8.33k	0.0073% € 446.8k
Peter Everingham	Independent Non-Executive Director	2.7yrs	AU$3.89k	0.0014% € 89.2k
Tracey Batten	Independent Non-Executive Director	7.3yrs	AU$4.22k	0.0018% € 112.0k
David Fagan	Independent Non-Executive Director	10.7yrs	AU$4.23k	0.0017% € 105.2k
Gerard Dalbosco	Independent Non-Executive Director	3.5yrs	AU$4.23k	0.0026% € 162.5k
Jay Weatherill	Independent Non-Executive Director	less than a year	AU$1.10k	0.00061% € 37.5k

3.5yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MPV wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Medibank Private Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

High number of new directors

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Independent Non-Executive Director recently bought €102k worth of stock

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings released: EPS: AU$0.18 (vs AU$0.19 in FY 2023)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 18%

Now 35% undervalued after recent price drop

High number of new directors

First half dividend of AU$0.072 announced

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Now 20% undervalued after recent price drop

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Now 20% undervalued

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Full year 2022 earnings released: EPS: AU$0.14 (vs AU$0.16 in FY 2021)

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought €102k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Upcoming dividend of AU$0.069 per share

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

Medibank Private Limited Provides Earnings Guidance for 2022

CEO & Director Craig Drummond has left the company

Revenue misses expectations

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

New 90-day high: €1.88

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: €1.85

New 90-day high: €1.72

Independent Non-Executive Director recently bought €70k worth of stock

New 90-day low - €1.65

Full year earnings released - EPS €0.11

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd